Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence,pattern,and comparison of natural course

Abstract

Objective

Osteonecrosis (ON), also known as avascular necrosis, is characterized by the collapse of the architectural bone structure secondary to the death of the bone marrow and trabecular bone. Osteonecrosis may accompany many conditions, especially rheumatic diseases. Among rheumatic diseases, osteonecrosis is most commonly associated with systemic lupus erythematosus (SLE). We assessed prevalence and distribution pattern of symptomatic ON in patients with SLE and compare the natural courses of hip and knee ON.

Methods

912 SLE patients admitted between 1981 and 2012 were reviewed. SLE patients with symptomatic ON were retrospectively identified both from the existing SLE/APS database. The prevalence of symptomatic ON was calculated; with ON, the joint involvement pattern was determined by examining the distribution of the joints involved, and then the data about the hip and knee joints were entered in the Kaplan-Meier analysis. Kaplan-Meier methods were used to calculate 5- and 10-year rates of ON-related hip (the hip group) and knee survival (the knee group).

Results

Symptomatic ON developed in various joints in 97 of 912 patients with SLE, and the overall prevalence of ON was detected as 10.6%. The mean age at the time of SLE and ON diagnoses were 27.9 ± 9.9 (14–53) and 34.2 ± 11.3 (16–62) years, respectively. The mean duration from diagnosis of SLE to the first development of ON was 70.7± 60.2 (range = 0–216) months. The most common site for symptomatic ON was the hips (68%, n=66), followed by the knees (38%, n = 37). According to Kaplan-Meier analysis, hip and knee joint survival rates associated with 5-year ON were 51% and 88%, and 10-year survival rates were 43% and 84%, respectively.

Conclusion

We observed that the prevalence of symptomatic ON in patients with SLE was 10.6%. With the estimated 10-year survival rates of 40% versus 84% for the hip and knee joints, respectively, hip involvement may demonstrate a more aggressive course to end-stage osteoarthritis than the knee involvement.

Keywords

Osteonecrosis systemic lupus erythematosus natural course

Get full access to this article

View all access options for this article.

References

Assouline-Dayan

Chang

Greenspan

Shoenfeld Y and Gershwin ME. Pathogenesis and natural history of osteonecrosis. In: Seminars in arthritis and rheumatism (Marc C Hochberg). Amsterdam: Elsevier, 2002, pp. 94–124.

Shah

Racine

Jones

and Aaron RK. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskel Med 2015; 8: 201–209.

Gladman

Dhillon

and Urowitz MB. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus 2018; 27: 76–81.

Kallas

and Petri

Predictors of osteonecrosis in systemic lupus erythematosus: A prospective cohort study. Arthritis Care Res. Epub ahead of print 20 December 2020. DOI: 10.1002/acr.24541.

Gladman

Urowitz

Chaudhry-Ahluwalia

Hallet DC and Cook RJ. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 761–765.

Dubois

and Cozen

Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus.

J Am Med Assoc 1960; 174: 966–971.

Abu-Shakra

Buskila

and Shoenfeld

Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol 2003; 25: 13–23.

Zhang

Fan

Zhang

Chen X and Liu Y. Comparison of sartorius muscle-pedicle and circumflex iliac deep bone flap grafts in the treatment of early non-traumatic osteonecrosis of femoral head in young adults. Acta Orthop Traumatol Turc 2019; 53: 255–259.

Steinberg

Hayken

and Steinberg

DR.

A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 1995; 77: 34–41.

10.

Mont

Baumgarten

RifaI

RifaI ADO, Bluemke DA and Jones LC. Atraumatic osteonecrosis of the knee. J Bone Joint Surg 2000; 82: 1279.

11.

Mont

Marker

Zywiel

and Carrino JA. Osteonecrosis of the knee and related conditions. J Am Acad Orthopaed Surg 2011; 19: 482–494.

12.

Gladman

Chaudhry-Ahluwalia

Ibañez

Bogoch E and Urowitz MB. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 2226–2229.

13.

Sugano

Ohzono

Masuhara

Takaoka K and Ono K. Prognostication of osteonecrosis of the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging. Clin Orthopaed Relat Res 1994; 305: 190–199.

14.

Nagasawa

Tsukamoto

Tada

, et al. Imaging study on the mode of development and changes in avascular necrosis of the femoral head in systemic lupus erythematosus: long-term observations. Rheumatology 1994; 33: 343–347.

15.

Sayarlioğlu

Yuzbasioglu

Inanc

, et al. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int 2012; 32: 177–182.

16.

Lee

Kwok

Jung

, et al. Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus 2014; 23: 39–45.

17.

Joo

Sung

Y-K

Shim

J-S

, et al. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study. Rheumatol Int 2015; 35: 879–886.